2019
Quarterly rpt on consolidated results for the financial period ended 31/03/2019
NOVA MSC BERHAD 28 May 2019
Change in Boardroom – MR CHAN WING KONG
NOVA MSC BERHAD 07 May 2019 Date of change 28 May 2019 Name MR CHAN WING KONG Age 62 Gender Male Nationality Singapore Designation Group Chief Executive Officer Directorate Executive Type of change Resignation Reason In line with the Group’s succession planning. Details of any disagreement that he/she has with the Board of Directors No Whether there are any matters…
Change in Principal Officer – MR LAI TEIK KIN
NOVA MSC BERHAD 07 May 2019 Date of change 28 May 2019 Name MR LAI TEIK KIN Age 55 Gender Male Nationality Singapore Type of change Appointment Designation Group Chief Executive Officer Qualifications No Qualifications Major/Field of Study Institute/University Additional Information 1 Degree Surveying University of Queensland, Australia Working experience and occupation Earlier in his career and before co-founding the…
Change in Principal Officer – MR CHAN WING KONG
NOVA MSC BERHAD 07 May 2019 Date of change 28 May 2019 Name MR CHAN WING KONG Age 62 Gender Male Nationality Singapore Type of change Others Designation Group Chief Executive Officer Description As part of succession planning, Mr Chan will step down as Group Chief Executive Officer and re-designated as Advisor with effect from 28 May 2019.
Change in Boardroom – MR LAI TEIK KIN
NOVA MSC BERHAD 07 May 2019 Date of change 28 May 2019 Name MR LAI TEIK KIN Age 55 Gender Male Nationality Singapore Designation Group Chief Executive Officer Directorate Executive Type of change Appointment Qualifications No Qualifications Major/Field of Study Institute/University Additional Information 1 Degree Surveying University of Queensland, Australia. Working experience and occupation Earlier in his career and before…
DEEP LEARNING IN ESTIMATING PREVALENCE AND SYSTEMIC RISK FACTORS FOR DIABETIC RETINOPATHY: A MULTI-ETHNIC STUDY
Apr 2019 – In any community, the key to understanding the burden of a specific condition is to conduct an epidemiological study. The deep learning system (DLS) recently showed promising diagnostic performance for diabetic retinopathy (DR). AIM: To use DLS as the grading tool, instead of human assessors, to determine the prevalence and the systemic cardiovascular risk factors for DR…
VESALIUS IMPLEMENTED AT HONGKONG INTEGRATED ONCOLOGY CENTRE, KOWLOON
Apr 2019–Originally located in the heart of Hong Kong island, Hong Kong Integrated Oncology Centre (HKIOC) has extended in the densely populated Kowloon to serve the community in the northern part of Hong Kong, on the mainland across Victoria Harbour. Instead of implementing a local & separate IT system, users from this new medical centre connected to their centralised VESALIUS…
General Meetings: Outcome of Meeting
NOVA MSC BERHAD 10 Apr 2019
ARTIFICIAL INTELLIGENCE IN DIABETIC EYE DISEASE SCREENING
Mar 2019 – Systematic or national screening programs for diabetic retinopathy (DR) and diabetic macular edema (DME), using digital fundus photography and optical coherence tomography (OCT), are currently implemented at primary care level, aiming to provide timely referral for vision-threatening DR and DME to ophthalmologists for timely treatment and vision loss prevention. However, interpretation of retinal images requires specialized knowledge…
NOVA LAUNCHES MOBILE APP TO BOOST PATIENT EXPERIENCE
Mar 2019–Nova has launched a mobile application to improve hospital’s engagement with their patients and visitors alike on most pervasive of digital platforms. The mobile app, named VESALIUS.m (mobile) is geared towards boosting customer engagement with features to allow visitors to browse for doctors within the selected hospital for information such as clinical specialisation, qualifications and working hours. With doctor…
GENERAL MEETINGS: Notice of Meeting
NOVA MSC BERHAD 25 Mar 2019